Banook Group
Yasmin Khan has extensive work experience in the healthcare industry. From April 2003 to April 2006, they worked as a Datamanager at Cardiabase. In April 2006, they joined the Banook Group as an Operations Manager, where they played a crucial role in providing cardiac safety, central imaging, and endpoint adjudication services to various organizations involved in clinical trials. Later, in March 2020, Yasmin was promoted to the position of Chief Operating Officer at Banook Group, contributing to the company's mission of developing innovative solutions in healthcare.
Yasmin Khan began their education in 2000 at University UHP Nancy 1, where they pursued a Master's degree in Computer Science. Yasmin successfully completed their Master's degree in 2001. Afterward, they enrolled at LORIA University UHP Nancy 1 from 2001 to 2002, where they specialized in Bioinformatics and obtained a DEA degree.
Banook Group
Banook Group is one of the few established international providers capable of supplying cardiac safety, central imaging and endpoint adjudication services to pharmaceutical, medical device and biotech companies, CROs and nonprofit organizations. Its mission is to help its clients invent tomorrow’s healthcare, using qualitative, reliable and innovative solutions in early to late stage clinical trials and ultimately to bring new solutions to the market for the benefit of patients worldwide. Its medical and regulatory expertise, quality-driven approach and team availability make the Banook Group a key player for clinical trial services. Founded in 1999, Banook Group is a non-listed family company. Financially stable and strong, the group operates on an international scale, maintaining offices at its headquarters in Nancy (France) and in the United States (Mystic, CT). To learn more about the Banook Group and its subsidiaries (formerly CardiaBase, Banook Central Imaging and Banook Inc.), please visit our new website www.banookgroup.com